Drug Target Review – Issue #2 2015

In Issue #2 2015 of Drug Target Review:

• FOREWORD: Academic drug discovery in neurodegeneration: a new approach to an ageing problem
  Dr Eric Karran, Director of Research, Alzheimer’s Research UK
• DRUG DISCOVERY: A new dawn in academic and pharma collaboration – a UK perspective
  Justin Bryans, MRC Technology’s Centre for Therapeutics Discovery
• IN-DEPTH FOCUS: SCREENING
  Featuring articles from Kenji Schorpp and Kamyar Hadian, Institute of Molecular Toxicology and Pharmacology, Sheraz Gul, Fraunhofer-IME SP and Horst Flotow, Singapore Screening Centre. Plus, Thermo Fisher Scientific’s Market and Product Line Manager Tarja Hirvensalo discusses screening and imaging solutions
• HIT-TO-LEAD: From hype to hope: challenging the norm in lead discovery
  Andy Merritt, MRC Technology Centre for Therapeutics Discovery
• ANTIBODIES: Developing antibody therapeutics
  David Matthews, MRC Technology
• IN-DEPTH FOCUS: STEM CELLS
  With articles from Dennis Schade, Technical University of Dortmund, Arne Hansen, University Medical Center Hamburg-Eppendorf and DZHK, Boris Greber, Max Planck Institute for Molecular Biomedicine, and Ginika J. Jideofor and Jeff D. Newman, Cranfield Institute of Health
• KINASES: Novel approaches to targeting protein tyrosine kinases
  Danielle McCullough and Dr Carol Trim, Canterbury Christ Church University